Table 2 Adverse events possibly and probably related to the infusion

From: Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report

Adverse events

AEs â©ľgrade 3(n=11)

Any grade(n=11)

ALT elevation

0

2

AST elevation

0

1

Hyperuricaemia

0

2

Hypoalbuminaemia

0

1

Hypokalemia

1

1

LDH elevation

0

2

Exudative inflammation of the lungs

0

1

Herpes zoster

1

1

  1. Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase.
Back to article page